Farmaceutica REMEDIA S.A., total return of 13.3% in first 5 months of the year

June 3, 2013
News

Farmaceutica REMEDIA shares brought a gain of 13.3% in first 5 months of the year, writes Zf in the 06/03/2013 edition.

Share price variation was 5.8% and dividend yield was 7.5%.

Share this post

Related news

REMEDIA, an innovative company in the Romanian pharmaceutical industry – Interview of Mr. Valentin-Norbert TARUS, General Director of Farmaceutica REMEDIA for USA Today

06/03/2025

Read the full interview & report here.

The fourth consecutive year with a score of 10 for REMEDIA in investor communication, according to the VEKTOR evaluation

31/01/2025

For the fourth year in a row, Farmaceutica REMEDIA has achieved the top 10 in the VEKTOR by ARIR ranking for 2024. This acknowledgment reflects

RETEZAT 2024 International Contemporary Art Symposium, 19th edition

15/07/2024

The 19th edition of the “Retezat International Contemporary Art Symposium” took place from the beginning of July 2024 and ended with a vernissage of the

REMEDIA in the Top of the largest companies in the distribution of medicines in 2023

19/06/2024

REMEDIA, in the Top 10 of the largest companies in the distribution of medicines, according to the Business Yearbook of Romania 2024 – The biggest

Farmaceutica REMEDIA S.A., total return of 13.3% in first 5 months of the year

Related news

REMEDIA, an innovative company in the Romanian pharmaceutical industry – Interview of Mr. Valentin-Norbert TARUS, General Director of Farmaceutica REMEDIA for USA Today

The fourth consecutive year with a score of 10 for REMEDIA in investor communication, according to the VEKTOR evaluation

RETEZAT 2024 International Contemporary Art Symposium, 19th edition

REMEDIA in the Top of the largest companies in the distribution of medicines in 2023

Useful Links

Headquarters

Partners

Follow Remedia